Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease
ME Seifert, L De Las Fuentes, M Rothstein… - American journal of …, 2013 - karger.com
… of vascular stiffness), cIMT, or VC. This study does not lend support for further study of
phosphate binders in early-stage CKD because of the failure to affect phosphate homeostasis. A …
phosphate binders in early-stage CKD because of the failure to affect phosphate homeostasis. A …
… and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: baseline characteristics of the impact of phosphate reduction on vascular …
NM Lioufas, E Pedagogos, CM Hawley… - American journal of …, 2020 - karger.com
… the effect of the phosphate binder lanthanum carbonate on intermediate cardiovascular …
It is upregulated from an early stage of CKD and is an important biomarker in CKD-MBD. …
It is upregulated from an early stage of CKD and is an important biomarker in CKD-MBD. …
A randomized trial on the effect of phosphate reduction on vascular end points in CKD (IMPROVE-CKD)
ND Toussaint, E Pedagogos, NM Lioufas… - Journal of the …, 2020 - journals.lww.com
… kidney function, and … of effect of phosphate binders on cardiovascular intermediate markers
in our study was consistent with an open-labeled clinical trial, which randomized 120 patients …
in our study was consistent with an open-labeled clinical trial, which randomized 120 patients …
Con: Phosphate binders in chronic kidney disease
B Kestenbaum - Nephrology Dialysis Transplantation, 2016 - academic.oup.com
… Phosphate binders are prescribed to chronic kidney disease (CKD) patients based on
associations of serum phosphate … Null effects of phosphate binders on these hormones may reflect …
associations of serum phosphate … Null effects of phosphate binders on these hormones may reflect …
Effects of phosphate binding with sevelamer carbonate on cardiovascular structure and function in patients with early chronic kidney disease
CD Chue - 2013 - etheses.bham.ac.uk
… oral, non-calcium-based phosphate binder, are assessed in a … trial of 120 patients with stage
3 chronic kidney disease. … the burden of cardiovascular disease caused by early stage CKD, …
3 chronic kidney disease. … the burden of cardiovascular disease caused by early stage CKD, …
… outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease …
N Lioufas, ND Toussaint, E Pedagogos, G Elder… - BMJ open, 2019 - bmjopen.bmj.com
… Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney
disease… calcium-based phosphate binders in patients with chronic kidney disease: a systematic …
disease… calcium-based phosphate binders in patients with chronic kidney disease: a systematic …
Pro: Should phosphate binders be used in chronic kidney disease stage 3–4?
A Bellasi - Nephrology Dialysis Transplantation, 2016 - academic.oup.com
… trials that have investigated the impact of phosphate binders in CKD patients. The aim of
the … view on the phosphate binder use in non-dialysis dependent CKD patients (NDD-CKD). …
the … view on the phosphate binder use in non-dialysis dependent CKD patients (NDD-CKD). …
Optimal use of phosphate binders in chronic kidney disease
M Sonikian, E Papachristou… - Expert opinion on …, 2013 - Taylor & Francis
… In conclusion, many studies showed that lanthanum carbonate has similar clinical adverse
effects with other phosphate binders, arising mostly from GI tract. Studies in humans did not …
effects with other phosphate binders, arising mostly from GI tract. Studies in humans did not …
Systematic review and meta-analyses of the effects of phosphate-lowering agents in nondialysis CKD
… those with cardiovascular disease, but normal kidney function, … effects on PWV between
the noncalcium phosphate binder … phosphate binders also had uncertain effects on vascular …
the noncalcium phosphate binder … phosphate binders also had uncertain effects on vascular …
[HTML][HTML] Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease
… The non-calcium-containing phosphate binder sevelamer has been linked to slowing the …
We demonstrated its beneficial effect for arterial stiffness parameters in dialysis patients …
We demonstrated its beneficial effect for arterial stiffness parameters in dialysis patients …